Dobbelaer R - Search Results

1

Validation of alternative methods for the potency testing of vaccines.

Hendriksen C, Spieser JM, Akkermans A, Balls M, Bruckner L, Cussler K, Daas A, Descamps J, Dobbelaer R, Fentem J, Halder M, van der Kamp M, Lucken R, Milstien J, Sesardic D, Straughan D, Valadares A. Hendriksen C, et al. Among authors: dobbelaer r. Altern Lab Anim. 1998 Nov-Dec;26(6):747-61. Altern Lab Anim. 1998. PMID: 26042581 No abstract available.

2

European union regulatory developments for new vaccine adjuvants and delivery systems.

Sesardic D, Dobbelaer R. Sesardic D, et al. Among authors: dobbelaer r. Vaccine. 2004 Jun 23;22(19):2452-6. doi: 10.1016/j.vaccine.2003.11.071. Vaccine. 2004. PMID: 15193409 Review.

3

Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).

Dobbelaer R, Daas A, Milne C. Dobbelaer R, et al. Pharmeuropa Bio. 2004 Jan;2003(2):77-90. Pharmeuropa Bio. 2004. PMID: 14960264

4

Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1.

Dobbelaer R, Daas A, Esposito-Farese ME. Dobbelaer R, et al. Pharmeuropa Spec Issue Biol. 2001 Aug;2001(1):15-23. Pharmeuropa Spec Issue Biol. 2001. PMID: 11705098 No abstract available.

5

WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland.

Corbel MJ, Das RG, Lei D, Xing DK, Horiuchi Y, Dobbelaer R; WHO Working Group. Corbel MJ, et al. Among authors: dobbelaer r. Vaccine. 2008 Apr 7;26(16):1913-21. doi: 10.1016/j.vaccine.2008.02.013. Epub 2008 Feb 21. Vaccine. 2008. PMID: 18336960

6

The system of mutual recognition of batch release in the EU--implications for combined vaccines.

Dobbelaer R. Dobbelaer R. Biologicals. 1994 Dec;22(4):377-80. doi: 10.1006/biol.1994.1057. Biologicals. 1994. PMID: 7779364 No abstract available.

7

Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002.

Knezevic I, Griffiths E, Reigel F, Dobbelaer R. Knezevic I, et al. Among authors: dobbelaer r. Vaccine. 2004 May 7;22(15-16):1836-41. doi: 10.1016/j.vaccine.2003.11.051. Vaccine. 2004. PMID: 15168689 No abstract available.

8

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH. Walker KB, et al. Among authors: dobbelaer r. Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Vaccine. 2010. PMID: 20074686 Review.

9

WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.

Xing DK, Corbel MJ, Dobbelaer R, Knezevic I. Xing DK, et al. Among authors: dobbelaer r. Vaccine. 2007 Apr 12;25(15):2749-57. doi: 10.1016/j.vaccine.2006.09.050. Epub 2006 Sep 29. Vaccine. 2007. PMID: 17368348

10

Collaborative study for the establishment of a European Phamacopoeia Biological reference preparation for Bordetella pertussis mouse antiserum for serological potency testing of acellular pertussis vaccines.

Poirier B, Bornstein N, Andre M, Marmonier D, Pares M, Vanhooren G, Rautmann G, Behr-Gross ME, Dobbelaer R, Fuchs F. Poirier B, et al. Among authors: dobbelaer r. Biologicals. 2003 Mar;31(1):25-38. doi: 10.1016/s1045-1056(02)00075-1. Biologicals. 2003. PMID: 12623057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters